Up the Creek with a Paddle by Boyle Mary Bradley
In 1986, when I first discovered LDN, if I had Mary Boyle Bradley on my team, this drug would have been approved, marketed and manufactured by a reputable pharmaceutical company. I have no doubt about that. Dr. Bernard Bihari The story is simple. It is about love, life and hope. After years of battling with the onslaught of her husband's Primary Progressive Multiple Sclerosis, Mary stumbled on a little known doctor in New York City, Dr. Bernard Bihari. Many people on the internet claimed that Dr. Bihari knew how to stop every type of MS from progressing. Even better, it was claimed that he could help everyone with an autoimmune disorder, ranging from psoriasis to AIDS. It was claimed that Dr. Bihari could help them with Low Dose Naltrexone (LDN). Eventually, Mary's husband took a leap of faith and put Dr. Bihari's work to the test. LDN worked. It stopped his MS from progressing. Since September 2002, a worldwide campaign has ignited with passionate momentum to get LDN medically recognized as a treatment for MS and all autoimmune disorders. LDN is a cheap, generic, out of patent drug with no known side-effects. Despite the fact that there is no financial incentive to entice any pharmaceutical company to investigate new uses for Naltrexone, the ambition is for LDN to hit the masses and improve the lives of millions. Small scale LDN clinical trials are finally making progress across the globe and are paving the way for a much better future for everyone who suffers from an autoimmune disorder.
